Research Papers

25 of 1710 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Cardioprotective function of sclerostin by reducing calcium deposition, proliferation, and apoptosis in human vascular …
González-Salvatierra S; García-Fontana C; Lacal J; Andújar-Vera F; Martínez-Heredia L; Sanabria-de la Torre R; Ferrer-Millán M; Moratalla-Aranda E; Muñoz-Torres M; García-Fontana B.
Cardiovasc Diabetol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Association between high sensitivity cardiac troponin and mortality risk in the non-diabetic population: findings from …
Liu L; Cheng YT; Xu A; Cheung BMY.
Cardiovasc Diabetol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Assessment of left atrioventricular coupling and left atrial function impairment in diabetes with and without hypertens…
Shi R; Jiang YN; Qian WL; Guo YK; Gao Y; Shen LT; Jiang L; Li XM; Yang ZG; Li Y.
Cardiovasc Diabetol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The triglyceride-glucose index predicts 1-year major adverse cardiovascular events in end-stage renal disease patients …
Xie E; Ye Z; Wu Y; Zhao X; Li Y; Shen N; Gao Y; Zheng J.
Cardiovasc Diabetol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Triglyceride-glucose index is associated with poor prognosis in acute coronary syndrome patients with prior coronary ar…
Dong S; Zhao Z; Huang X; Ma M; Yang Z; Fan C; Han H; Wang Z; Shi D; Zhou Y.
Cardiovasc Diabetol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Predictive value of the stress hyperglycemia ratio in dialysis patients with acute coronary syndrome: insights from a m…
Xie E; Ye Z; Wu Y; Zhao X; Li Y; Shen N; Gao Y; Zheng J.
Cardiovasc Diabetol (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Glycemic control, HbA1c variability, and major cardiovascular adverse outcomes in type 2 diabetes patients with elevate…
Pei J; Wang X; Pei Z; Hu X.
Cardiovasc Diabetol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
C-reactive protein during pregnancy and in the early postpartum predicts adverse metabolic health outcomes at 1 year po…
Quansah DY; Horsch A; Gilbert L; Donath MY; Puder JJ; MySweetheart research group.
Cardiovasc Diabetol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Klotho inhibits renal ox-LDL deposition via IGF-1R/RAC1/OLR1 signaling to ameliorate podocyte injury in diabetic kidney…
Jiang W; Gan C; Zhou X; Yang Q; Chen D; Xiao H; Dai L; Chen Y; Wang M; Yang H; Li Q.
Cardiovasc Diabetol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Triglyceride-glucose index is associated with severe obstructive coronary artery disease and atherosclerotic target les…
Shali S; Luo L; Yao K; Sun X; Wu H; Zhang S; Xu L; Gao W; Li J; Qian J; Zheng Y; Dai Y; Ge J; the GRAND investigators.
Cardiovasc Diabetol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Non-invasive detection of early microvascular changes in juveniles with type 1 diabetes.
Bogusz-Górna K; Polańska A; Dańczak-Pazdrowska A; Żaba R; Sumińska M; Fichna P; Kędzia A.
Cardiovasc Diabetol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Triglyceride-glucose index is associated with recurrent revascularization in patients with type 2 diabetes mellitus aft…
Chen Q; Xiong S; Zhang Z; Yu X; Chen Y; Ye T; Yang S; Qi L; Chen X; Liu H; Zheng J; Cai L.
Cardiovasc Diabetol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes …
Zhang Q; Xiao S; Jiao X; Shen Y.
Cardiovasc Diabetol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Chronic kidney outcomes associated with GLP-1 receptor agonists versus long-acting insulins among type 2 diabetes patie…
Peng ZY; Yang CT; Lin WH; Yao WY; Ou HT; Kuo S.
Cardiovasc Diabetol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Elevated high-sensitivity C-reactive protein levels increase the risk of new-onset cardiac conduction disorders.
Wu L; Wu M; Zhao D; Chen S; Wang G; Xu L; Wang Y; An L; Wu S; Miao C; Hong J.
Cardiovasc Diabetol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Timing of SGLT2i initiation after acute myocardial infarction.
von Lewinski D; Kolesnik E; Aziz F; Benedikt M; Tripolt NJ; Wallner M; Pferschy PN; von Lewinski F; Schwegel N; Holman RR; Oulhaj A; Moertl D; Siller-Matula J; Sourij H.
Cardiovasc Diabetol (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
The neutrophil-lymphocyte ratio as a risk factor for all-cause and cardiovascular mortality among individuals with diab…
Dong G; Gan M; Xu S; Xie Y; Zhou M; Wu L.
Cardiovasc Diabetol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Subclinical left ventricular deformation and microvascular dysfunction in T2DM patients with and without peripheral neu…
Li XM; Shi R; Shen MT; Yan WF; Jiang L; Min CY; Liu XJ; Guo YK; Yang ZG.
Cardiovasc Diabetol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Diabetes- versus smoking-related thrombo-inflammation in peripheral artery disease.
Alnima T; Meijer RI; Spronk HMH; Warlé M; Cate HT.
Cardiovasc Diabetol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Serum branch-chained amino acids are increased in type 2 diabetes and associated with atherosclerotic cardiovascular di…
Moreno-Vedia J; Llop D; Rodríguez-Calvo R; Plana N; Amigó N; Rosales R; Esteban Y; Girona J; Masana L; Ibarretxe D.
Cardiovasc Diabetol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Triglyceride-glucose index and heart failure: a systematic review and meta-analysis.
Khalaji A; Behnoush AH; Khanmohammadi S; Ghanbari Mardasi K; Sharifkashani S; Sahebkar A; Vinciguerra C; Cannavo A.
Cardiovasc Diabetol (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Implication of diabetic status on platelet reactivity and clinical outcomes after drug-eluting stent implantation: resu…
Jeon KH; Jeong YH; Chae IH; Kim BK; Joo HJ; Chang K; Park Y; Song YB; Ahn SG; Lee SY; Cho JR; Her AY; Kim HS; Kim MH; Lim DS; Shin ES; Suh JW; PTRG-DES Consortium Investigators.
Cardiovasc Diabetol (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
BMI-based obesity classification misses children and adolescents with raised cardiometabolic risk due to increased adip…
Zapata JK; Azcona-Sanjulian MC; Catalán V; Ramírez B; Silva C; Rodríguez A; Escalada J; Frühbeck G; Gómez-Ambrosi J.
Cardiovasc Diabetol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The role of oxidative stress in diabetes mellitus-induced vascular endothelial dysfunction.
An Y; Xu BT; Wan SR; Ma XM; Long Y; Xu Y; Jiang ZZ.
Cardiovasc Diabetol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Left ventricular remodeling response to SGLT2 inhibitors in heart failure: an updated meta-analysis of randomized contr…
Carluccio E; Biagioli P; Reboldi G; Mengoni A; Lauciello R; Zuchi C; D'Addario S; Bardelli G; Ambrosio G.
Cardiovasc Diabetol (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared